202 related articles for article (PubMed ID: 9691382)
1. [Use of gelofusin in the clinics of the St. Petersburg's I.P. Pavlov State Medical University].
Baryshev BA; Doĭnikov DN; Khabarova IG; Kovalev MG
Vestn Khir Im I I Grek; 1998; 157(2):51-4. PubMed ID: 9691382
[TBL] [Abstract][Full Text] [Related]
2. [Effectiveness and safety of using 6% hydroxyethyl starch 130/04 and 4% modified liquid gelatin in neurosurgical patients with massive intraoperative blood loss].
Israelian LA; Lubnin AIu
Anesteziol Reanimatol; 2009; (5):42-8. PubMed ID: 20491145
[TBL] [Abstract][Full Text] [Related]
3. [Clinical experience with the use of gelofusin (gelatin) in anesthesiology, resuscitation and intensive care].
Eremenko AA; Kuslieva EV
Anesteziol Reanimatol; 2001; (3):58-61. PubMed ID: 11510363
[TBL] [Abstract][Full Text] [Related]
4. [Succinate-polymerized gelatin as a plasma substitute].
Tosaki Y; Yasusumi N; Takaori M; Matsuki H; Okumura M
Nihon Rinsho; 1968 May; 26(5):1227-33. PubMed ID: 5749805
[No Abstract] [Full Text] [Related]
5. Transient massive proteinuria after gelatin-derived plasma expander (Gelofusine®) administration.
Raghunath V; Marshall G; Ratanjee SK; Francis RS
Nephrology (Carlton); 2013 Mar; 18(3):240-1. PubMed ID: 23432751
[No Abstract] [Full Text] [Related]
6. [Intraoperative anaphylactic/anaphylactoid reaction to infusion of a modified liquid gelatin].
Israelian LA; Lubnin AIu
Anesteziol Reanimatol; 2004; (2):36-40. PubMed ID: 15206275
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of the effectiveness and safety of synthetic colloid solutions in the treatment of severe abdominal sepsis: a randomized comparative study].
Protsenko DN; Leĭderman IN; Grigor'ev EV; Kokarev EA; Levit AL; Gel'fand BR
Anesteziol Reanimatol; 2009; (5):9-13. PubMed ID: 19938709
[TBL] [Abstract][Full Text] [Related]
8. [Effect of different colloid volume-replacing solutions on a changed hemostasis system].
Bulanov AIu; Gorodetskiĭ VM; Shulutko EM; Vasil'ev SA; Orel EB; Malofeev VN; Shcherbakova OV; Mamonov VE; Strel'nikova TB
Anesteziol Reanimatol; 2004; (2):25-30. PubMed ID: 15206272
[No Abstract] [Full Text] [Related]
9. [Intraoperative application of acute normovolemic hemodilution].
Zhao SP; Cai HW; Liu ZS; Yang HW; Yang Y
Hunan Yi Ke Da Xue Xue Bao; 2000 Feb; 25(1):83-4. PubMed ID: 12212261
[TBL] [Abstract][Full Text] [Related]
10. [Hemodynamic efficacy of modified gelatin in patients with acute blood loss and sepsis].
Kochergina VV; Vlasenko AV; Moroz VV; Evdokimov EA; Iakovlev VN; Alekseev VG
Anesteziol Reanimatol; 2010; (3):45-50. PubMed ID: 20734846
[TBL] [Abstract][Full Text] [Related]
11. Is 6% hydroxyethyl starch 130/0.4 safe in coronary artery bypass graft surgery?
Ooi JS; Ramzisham AR; Zamrin MD
Asian Cardiovasc Thorac Ann; 2009 Aug; 17(4):368-72. PubMed ID: 19713332
[TBL] [Abstract][Full Text] [Related]
12. [Hemorrhage-hypovolemia: approaches to infusion-transfusion correction].
Mariutin PV; Levchenko LB; Uchvatkin VG; Mikhaĭlovich DV; Sorokin MF
Anesteziol Reanimatol; 1998; (3):35-41. PubMed ID: 9693432
[No Abstract] [Full Text] [Related]
13. [HES, dextran and gelatin--indications and tolerance].
Laubenthal H; Sirtl C
Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Apr; 33(4):251-5. PubMed ID: 9617425
[No Abstract] [Full Text] [Related]
14. Severe hypotension associated with angiotensin-converting enzyme inhibition in anaesthesia.
Powell CG; Unsworth DJ; McVey FK
Anaesth Intensive Care; 1998 Feb; 26(1):107-9. PubMed ID: 9513677
[TBL] [Abstract][Full Text] [Related]
15. A randomized, controlled, double-blind crossover study on the effects of isoeffective and isovolumetric intravenous crystalloid and gelatin on blood volume, and renal and cardiac hemodynamics.
Bradley CR; Bragg DD; Cox EF; El-Sharkawy AM; Buchanan CE; Chowdhury AH; Macdonald IA; Francis ST; Lobo DN
Clin Nutr; 2020 Jul; 39(7):2070-2079. PubMed ID: 31668721
[TBL] [Abstract][Full Text] [Related]
16. Anaphylaxis to Haemaccel and cross reactivity to Gelofusin.
Russell WJ; Fenwick DG
Anaesth Intensive Care; 2002 Aug; 30(4):481-3. PubMed ID: 12180589
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience with 120,000 units of modified fluid gelatin.
Lundsgaard-Hansen P; Tschirren B
Dev Biol Stand; 1980; 48():251-6. PubMed ID: 7274558
[TBL] [Abstract][Full Text] [Related]
18. [1st clinical trial of a new high-molecular-weight, gelatin-based plasma substitute].
Scholz PM; Rittmann WW; Müller W; Leutenegger A; Gruber UF
Schweiz Med Wochenschr; 1971 Jul; 101(27):987-94. PubMed ID: 5169067
[No Abstract] [Full Text] [Related]
19. Transient proteinuria after infusion of a gelatin plasma volume expander.
Ambühl PA; Müller V; Binswanger U
Clin Nephrol; 1999 Dec; 52(6):399-400. PubMed ID: 10604652
[No Abstract] [Full Text] [Related]
20. [Clinical plasma substitution with gelatin: A 12-year experience with 39,320 units of Physiogel].
Tschirren B; Affolter U; Elsässer R; Frehofer UA; Grawehr R; Müller PH; Lundsgaard-Hansen P
Infusionstherapie (1973); 1974 Dec; 1(8):651-62. PubMed ID: 4142946
[No Abstract] [Full Text] [Related]
[Next] [New Search]
